Results 181 to 190 of about 10,058 (190)
Some of the next articles are maybe not open access.
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
Nature Reviews Drug Discovery, 2009John D Imig, Bruce D Hammock
exaly
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann Sebastian de Bono
exaly
Author response for "Emerging Gut Microbial Glycoside Hydrolase Inhibitors"
null Mark Edward Kowalewski +1 moreopenaire +1 more source
Proceedings of the National Academy of Sciences of the United States of America, 2015
Qun Wan +2 more
exaly
Qun Wan +2 more
exaly
A panātumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
Ca-A Cancer Journal for CliniciansChadi Hage Chehade +2 more
exaly
Fatty acid amide hydrolase inhibitors and the marijuana debate
Lancet, The, 2001David Gurwitz, Abraham Weizman
exaly
Decision letter for "Emerging Gut Microbial Glycoside Hydrolase Inhibitors"
openaire +2 more sourcesGlycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine
Journal of Biological Chemistry, 2018Tian Liu, Qing Yang
exaly

